Platform and Technology Capabilities
Synoptek Expands its Operations in Pune, India
Technology Consulting and Assessment Services Help an International Training Institute Become a $300M Organization in 5 Years
In-House IT Teams vs. Outsourcing: Which Is Right for You?
Technology as a Driver in CX Transformation and Business Growth
Home / Insights / Case Study / Dynamics 365 Business Central Implementation and Integration Services Help a Biopharmaceutical Company Standardize Processes, Improve Financial Reporting, and Ensure Compliance
Focused on the development of treatments for patients living with life-threatening and debilitating rare diseases, the biopharma company wanted to ramp up their US operations in anticipation of their drug approval in Q2. Although they had already implemented Dynamics 365 Business Central at their headquarters in Denmark, they wanted to extend the system to their Chicago location and replace the existing QuickBooks platform.
Through implementation of Business Central in Chicago, the biopharma company was looking to have a ‘Global Standard Template’ in anticipation of rollout to other countries over time. They wanted to implement a handful of Financial modules to track Revenue and Financial Inventory.
For this requirement, the biopharma company was looking for a service provider/partner with experience in life sciences, global capabilities that extend into EU as well as strong Business Central know-how. The company partnered with Synoptek to extend their functional as well as technology capabilities to develop and deliver a time-phased, resourced, costed plan to rollout D365 Business Central.
To meet the biopharma company’s requirement of enabling financial processing, expense reporting, and process standardization, Synoptek leveraged Dynamics Platform to extend functional as well as technology capabilities while constantly paving the way for process standardization.
As part of the engagement, we carried out the following activities:
With Synoptek’s help and implementation support, the biopharma company was able to:
© 2023 Synoptek, LLC. All Rights Reserved.